Learning to cope with chronic pain
Part of Pain clinical trials.
This study tests a program called 'Learn to Act' that helps people with chronic pain learn how to cope better by improving their understanding of mental health. It may help you feel more in control and improve your well-being.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You live in Portugal.
- A doctor has told you that you have chronic pain (pain lasting more than 3 months).
- You can attend the sessions.
- You are not currently receiving regular psychological support (more than twice a year).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a brief nurse-delivered program to help people in rural areas learn skills to manage chronic pain and reduce its impact on daily life.
This study tests a virtual group program that combines medical care with integrative approaches like mindfulness and gentle movement to help adults manage chronic musculoskeletal pain.
This trial tests an internet-based program to help people manage chronic pain. You participate from home using a computer or tablet.
This trial tests a training program to help people accept chronic pain and emotional distress. It looks at how thinking patterns might help or hinder progress.
This study tests an online program to help teens manage chronic pain and improve daily functioning. It uses acceptance and commitment therapy (ACT) to build coping skills and reduce suffering.
This study looks at how your thoughts and feelings about pain affect your overall well-being. By answering questionnaires, you'll help researchers understand the role of accepting pain and feeling confident in managing it, which could lead to better pain treatments.
Hear when a new Chronic pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.